A female breast‑cancer survivor presents with new unilateral tongue deviation; her routine brain MRI performed on [DATE] was reported negative. What is the most likely cause and what further diagnostic work‑up and management should be pursued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Unilateral Tongue Deviation in a Breast Cancer Survivor: Diagnostic Approach and Management

Most Likely Diagnosis

The most likely cause is leptomeningeal carcinomatosis or skull-base metastasis involving the hypoglossal nerve, and the negative brain MRI from [DATE] does not exclude these diagnoses—immediate contrast-enhanced MRI of the brain and skull base with dedicated hypoglossal nerve imaging is mandatory. 1

Critical Diagnostic Pitfall

A routine brain MRI—even if recently negative—is insufficient to evaluate hypoglossal nerve palsy because standard protocols often miss leptomeningeal disease, perineural tumor spread, and skull-base lesions along the hypoglossal canal. 1, 2 The hypoglossal nerve travels from the medulla through the skull base to the sublingual space, and pathology anywhere along this trajectory can cause isolated tongue deviation 3. Standard brain MRI protocols frequently fail to adequately image the skull base and hypoglossal canal, leading to missed diagnoses 2.

Immediate Diagnostic Work-Up

Required Imaging

  • Obtain gadolinium-enhanced brain and skull-base MRI immediately, specifically requesting imaging of the entire hypoglossal nerve pathway from the medulla through the hypoglossal canal to the sublingual space. 1, 3 This is distinct from standard brain MRI protocols.

  • Add post-contrast FLAIR sequences to the MRI protocol to evaluate for leptomeningeal disease, which is particularly common in HER2-positive and triple-negative breast cancer. 1 Leptomeningeal carcinomatosis is the primary concern when isolated cranial neuropathy occurs in metastatic breast cancer 1.

  • Do not rely on MR angiography (MRA) alone—MRA evaluates only vascular structures and will miss parenchymal, leptomeningeal, and bony lesions that commonly cause cranial neuropathies in cancer patients. 1

Cerebrospinal Fluid Analysis

  • If leptomeningeal disease is suspected on imaging—or if MRI is negative despite high clinical suspicion—perform lumbar puncture with CSF cytology. 1 MRI sensitivity for leptomeningeal carcinomatosis is imperfect, and CSF cytology may provide the definitive diagnosis 1.

  • Do not delay CSF analysis when leptomeningeal disease is suspected, as early confirmation impacts treatment planning. 1

Management Based on Findings

If Leptomeningeal Metastases Confirmed

  • Convene a multidisciplinary discussion immediately, as no universally accepted standard of care exists for leptomeningeal disease. 1 Treatment options include intrathecal chemotherapy, systemic therapy, and radiation therapy 4.

  • For focal symptomatic lesions causing the hypoglossal neuropathy, focal radiation therapy is recommended. 1

  • Do not combine intrathecal methotrexate with radiation therapy due to increased risk of neurotoxicity. 1

If Skull-Base Metastasis Identified

  • When a skull-base metastasis involving the hypoglossal canal is identified, stereotactic radiosurgery or fractionated radiation to the lesion is the primary treatment. 1 Skull-base metastases are frequently missed on routine imaging but are a common cause of hypoglossal palsy in cancer patients 2.

Systemic Therapy Considerations

  • Continue systemic HER2-targeted therapy in HER2-positive patients if extracranial disease is otherwise controlled. 1 Up to 40-50% of patients with advanced HER2-positive breast cancer will experience brain or leptomeningeal relapse 5, 4.

  • For triple-negative breast cancer, recognize that brain metastases occur in up to 40-50% of advanced cases with shorter intervals from primary diagnosis to CNS involvement. 5

If All Imaging Is Negative

  • Institute serial MRI surveillance every 2-4 months to detect subsequently apparent disease. 1 Isolated hypoglossal nerve palsy in a breast cancer survivor warrants close monitoring even when initial imaging is negative 6, 3.

  • Consider idiopathic isolated hypoglossal nerve palsy as a diagnosis of exclusion only after thorough investigation. 6 This is extremely rare and requires stepwise exclusion of all other causes 6.

Key Clinical Pearls

  • Breast cancer is the second most common cause of brain metastases after lung cancer, but routine surveillance imaging is not recommended in asymptomatic patients. 4 However, clinicians should have a low threshold for performing diagnostic brain MRI in the setting of any neurologic symptoms suggestive of brain involvement. 4

  • The presence of neurologic symptoms fundamentally changes the diagnostic approach—symptomatic patients require immediate comprehensive imaging regardless of recent negative studies. 4

  • Tongue denervation on imaging can be misinterpreted as a primary tongue base mass, showing T2-weighted hyperintensity of the involved hemitongue, protrusion into the oropharynx, and variable fatty infiltration. 2 Recognition of these patterns prevents misdiagnosis.

  • Internal carotid artery dissection at the skull base is another potential cause of hypoglossal palsy that must be excluded. 2

References

Guideline

Diagnostic and Management Guidelines for Isolated Hypoglossal Nerve Palsy in Metastatic Breast Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hypoglossal nerve palsy missed and misinterpreted: the hidden skull base.

Journal of computer assisted tomography, 2012

Research

Hypoglossal nerve palsy: a segmental approach.

Radiographics : a review publication of the Radiological Society of North America, Inc, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Brain Metastases in Triple-Negative Breast Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Idiopathic Isolated Unilateral Hypoglossal Nerve Palsy: A Report of 2 Cases and Review of the Literature.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2018

Related Questions

In a patient with a history of breast cancer who now has a new unilateral tongue deviation and a negative magnetic resonance angiogram, what is the most likely cause and what work‑up and management should be pursued?
What is all the essential information in breast cancer?
What could fluid near the 2nd rib on a breast ultrasound indicate in a patient, particularly a female over 40 with potential breast-related issues or family history of breast cancer?
What is the immediate treatment recommendation for a patient newly diagnosed with breast cancer who has not started chemotherapy?
What to assess in a patient with a history of breast cancer and current symptoms of cold calves?
What are the dosing instructions for alternating acetaminophen (Tylenol) and ibuprofen in an adult without contraindications such as severe liver disease, chronic kidney disease, active gastrointestinal ulcer, or allergy?
How should I initiate insulin therapy in a type 2 diabetes mellitus patient who is not achieving glycemic targets despite optimized lifestyle and oral medications?
What is the correct method to diagnose hypertension, including the number of blood pressure readings required and the interval between measurements?
What are the classes of antidiabetic medications?
What are the typical symptoms and clinical presentation of influenza, including common findings in adults, children, and high‑risk groups?
How should I start and titrate sertraline for an adult with depression or anxiety, especially if the patient is ≥65 years old or has hepatic impairment, and what duration of treatment is recommended before tapering?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.